Kevin M. Tuffy, MS

Senior Scientist
AstraZeneca

Disclosure(s): AstraZeneca: Employee, Stocks/Bonds

Kevin joined AstraZeneca in 2017, and is now a Senior Scientist within the Translational Medicine group as part of the AstraZeneca Vaccines and Immune Therapies unit. Kevin currently leads a team that focuses on the monitoring of phenotypic resistance of viral variants, including SARS-CoV-2, through clinical exploratory and surveillance endpoints. Kevin received his MS in Biomedical Sciences from Pennsylvania State University in 2016 while studying the potential nuclear function of human immunodeficiency virus type 1 Gag protein.

Poster(s):

• 1110 - AZD7442 (Tixagevimab/Cilgavimab) Demonstrates Potent In Vitro Activity Against SARS-CoV-2 Spike Variants Identified in Circulation and in Prophylaxis Clinical Studies
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET